1 April 2026 - Chinese biopharmaceutical company Abbisko Therapeutics Co Ltd (HKEX:02256) announced on Tuesday that its independently developed, highly selective, oral small-molecule FGFR4 inhibitor i...
2026 Copyright © News-Matic.com. All Rights Reserved
